Georges Imbert

3.5k total citations · 3 hit papers
17 papers, 2.8k citations indexed

About

Georges Imbert is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Georges Imbert has authored 17 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 5 papers in Neurology. Recurrent topics in Georges Imbert's work include Genetic Neurodegenerative Diseases (7 papers), Mitochondrial Function and Pathology (6 papers) and Alzheimer's disease research and treatments (4 papers). Georges Imbert is often cited by papers focused on Genetic Neurodegenerative Diseases (7 papers), Mitochondrial Function and Pathology (6 papers) and Alzheimer's disease research and treatments (4 papers). Georges Imbert collaborates with scholars based in France, Switzerland and United States. Georges Imbert's co-authors include Jean‐Louis Mandel, Yves Agid, Frédéric Saudou, C. R. Weber, Yvon Trottier, Didier Devys, Alexis Brice, Géraldine Cancel‐Tassin, Giovanni Stévanin and Gaël Yvert and has published in prestigious journals such as Nature, Nature Genetics and Analytical Chemistry.

In The Last Decade

Georges Imbert

17 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats

1996 706 citations Georges Imbert, Frédéric Saudou et al. Nature Genetics profile →
Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion

1997 599 citations Gilles David, Nacer Abbas et al. Nature Genetics profile →
Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias

1995 540 citations Yvon Trottier, Yves Lutz et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Georges Imbert France	11	2.3k	2.2k	860	246	240	17	2.8k
Judit Pallos United States	13	2.2k 1.0×	1.8k 0.8×	503 0.6×	287 1.2×	284 1.2×	16	2.9k
Gabriele Schilling United States	18	2.7k 1.2×	2.6k 1.2×	1.0k 1.2×	196 0.8×	138 0.6×	25	3.3k
Ben Woodman United Kingdom	26	2.4k 1.1×	2.0k 0.9×	644 0.7×	259 1.1×	179 0.7×	29	3.0k
Jean‐Paul Vonsattel United States	18	2.2k 1.0×	2.6k 1.2×	1.6k 1.9×	578 2.3×	139 0.6×	37	3.7k
Juliette Gafni United States	19	1.9k 0.9×	1.7k 0.8×	483 0.6×	221 0.9×	71 0.3×	19	2.7k
P. Shashidharan United States	25	699 0.3×	1.3k 0.6×	1.1k 1.2×	276 1.1×	146 0.6×	34	2.1k
Montserrat Arrasate Spain	18	2.1k 0.9×	1.7k 0.8×	892 1.0×	758 3.1×	82 0.3×	24	3.1k
Chuan-En Wang United States	17	1.3k 0.6×	1.2k 0.5×	498 0.6×	200 0.8×	79 0.3×	21	1.9k
Sandro Alves France	21	1.1k 0.5×	810 0.4×	265 0.3×	328 1.3×	190 0.8×	33	1.8k
Kimberly B. Kegel United States	23	2.0k 0.9×	1.8k 0.8×	660 0.8×	262 1.1×	76 0.3×	27	2.7k

Countries citing papers authored by Georges Imbert

Since Specialization

Citations

This map shows the geographic impact of Georges Imbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georges Imbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georges Imbert more than expected).

Fields of papers citing papers by Georges Imbert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georges Imbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georges Imbert. The network helps show where Georges Imbert may publish in the future.

Co-authorship network of co-authors of Georges Imbert

This figure shows the co-authorship network connecting the top 25 collaborators of Georges Imbert. A scholar is included among the top collaborators of Georges Imbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georges Imbert. Georges Imbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Eichler, Gabriel S., et al.. (2022). Democratizing data at Novartis through clinical trial data access. Drug Discovery Today. 27(6). 1533–1537. 1 indexed citations

Barve, Avantika, Hanns-Christian Tillmann, Georges Imbert, et al.. (2016). Impact of co-administration of fevipiprant (QAW039) and SLCO1B1 genotype on the PK of simvastatin and rosuvastatin. PA1108–PA1108. 1 indexed citations

Trenité, Dorothée Kasteleijn‐Nolst, Christian Brandt, Felix Rosenow, et al.. (2015). Dose‐dependent suppression of human photoparoxysmal response with the competitive AMPA/kainate receptor antagonist BGG492: Clear PK/PD relationship. Epilepsia. 56(6). 924–932. 23 indexed citations

Winblad, Bengt, Niels Andreasen, Lennart Minthon, et al.. (2012). Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study. The Lancet Neurology. 11(7). 597–604. 234 indexed citations

Winblad, Bengt, Martin R. Farlow, Kaj Blennow, et al.. (2011). P2‐083: Aβ‐specific antibodies induced by active immunotherapy CAD106 engage Aβ in plasma in AD patients. Alzheimer s & Dementia. 7(4S_Part_10). 3 indexed citations

Graf, Ana, Niels Andreasen, Marie‐Emmanuelle Riviere, et al.. (2010). P3‐275: Optimization of the treatment regimen with active Aß immunotherapy CAD106 in alzheimer patients. Alzheimer s & Dementia. 6(4S_Part_17). 2 indexed citations

Imbert, Georges, et al.. (2009). P3‐285: Antibody immune response in cynomolgus monkeys following treatment with the active Aß immunotherapy CAD106. Alzheimer s & Dementia. 5(4S_Part_14). 2 indexed citations

Boernsen, K. Olaf, et al.. (2005). Controlled Protein Precipitation in Combination with Chip-Based Nanospray Infusion Mass Spectrometry. An Approach for Metabolomics Profiling of Plasma. Analytical Chemistry. 77(22). 7255–7264. 75 indexed citations

Wittekindt, Oliver H., Anna Jauch, E. Omer Burgert, et al.. (1998). The human small conductance calcium-regulated potassium channel gene ( hSKCa3 ) contains two CAG repeats in exon 1, is on chromosome 1q21.3, and shows a possible association with schizophrenia. Neurogenetics. 1(4). 259–265. 35 indexed citations

10.

David, Gilles, Nacer Abbas, Giovanni Stévanin, et al.. (1997). Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nature Genetics. 17(1). 65–70. 599 indexed citations breakdown →

11.

Gourfinkel‐An, Isabelle, Géraldine Cancel‐Tassin, Yvon Trottier, et al.. (1997). Differential distribution of the normal and mutated forms of huntingtin in the human brain. Annals of Neurology. 42(5). 712–719. 32 indexed citations

12.

Imbert, Georges, Frédéric Saudou, Gaël Yvert, et al.. (1996). Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nature Genetics. 14(3). 285–291. 706 indexed citations breakdown →

13.

Trottier, Yvon, Yves Lutz, Giovanni Stévanin, et al.. (1995). Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature. 378(6555). 403–406. 540 indexed citations breakdown →

14.

Trottier, Yvon, Didier Devys, Georges Imbert, et al.. (1995). Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nature Genetics. 10(1). 104–110. 348 indexed citations

15.

Imbert, Georges & Jean‐Louis Mandel. (1995). The fragile X mutation. Mental Retardation and Developmental Disabilities Research Reviews. 1(4). 251–262. 7 indexed citations

16.

Trottier, Yvon, Georges Imbert, Annemarie Poustka, Jean‐Pierre Fryns, & Jean‐Louis Mandel. (1994). Male with typical fragile X phenotype is deleted for part of the FMR1 gene and for about 100 kb of upstream region. American Journal of Medical Genetics. 51(4). 454–457. 38 indexed citations

17.

Imbert, Georges, Christine Kretz, Keith Johnson, & Jean‐Louis Mandel. (1993). Origin of the expansion mutation in myotonic dystrophy. Nature Genetics. 4(1). 72–76. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact